George W. Hebard III
2013
In 2013, George W. Hebard III earned a total compensation of $432.3K as Interim Principal Executive Officer, Interim Chief Operating Officer and Secretary at Enzon Pharmaceuticals, a 16% decrease compared to previous year.
Compensation breakdown
| Salary | $428,519 |
|---|---|
| Other | $3,825 |
| Total | $432,344 |
Hebard received $428.5K in salary, accounting for 99% of the total pay in 2013.
Hebard also received $3.8K in other compensation.
Rankings
In 2013, George W. Hebard III's compensation ranked 9,818th out of 12,286 executives tracked by ExecPay. In other words, Hebard earned more than 20.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 9,818 out of 12,286 | 20th |
Division Manufacturing | 3,649 out of 4,612 | 21st |
Major group Chemicals And Allied Products | 1,157 out of 1,462 | 21st |
Industry group Drugs | 902 out of 1,156 | 22nd |
Industry Biological Products, Except Diagnostic Substances | 153 out of 196 | 22nd |
Source: SEC filing on May 15, 2015.
Hebard's colleagues
We found five more compensation records of executives who worked with George W. Hebard III at Enzon Pharmaceuticals in 2013.
2013
Andrew Rackear
Enzon Pharmaceuticals
General Counsel
2013
Aby Buchbinder
Enzon Pharmaceuticals
Former Vice President, Clinical Development
2013
Charles Conover
Enzon Pharmaceuticals
Former Senior Vice President of Research & Development, Program Management
2013
Timothy Daly
Enzon Pharmaceuticals
Chief Accounting Officer
2013
Richard Feinstein
Enzon Pharmaceuticals